Blue Horseshoe Stocks: Reviewing IMMU, EBIO & More

Immunomedics, Inc. IMMU

We began tracking IMMU last month, mentioning it for the first time on May 13th, and then again in a followup on the 20th. Our timeliness in bringing what was already a steady climber to the table, as you can plainly see on the chart below.

It’s been a solid few weeks for the stock since that time. It has risen from our observed low of 3.59 to a new high of 5.44 yesterday, marking a solid 52% PPS increase in just a short time. We can also see that the volume has been steadily creeping up as well.

The last time the stock was this overbought, we saw a leveling out but not much of a consolidation. We’ll look for a similar phenomenon to occur from this point forward, and for IMMU to ultimately continue its general uptrend until we see evidence to the contrary.


Eleven Biotherapeutics, Inc. EBIO

Speaking of plays we called last month that have enjoyed extended moves up, we’ve also got on update on EBIO this morning. We tagged this stock for observation in the first week of May, and would catch it trading at a low of .80.

From there it’s been a fairly steady climb, and yesterday it too shot to new highs. As of yesterday’s top mark of 2.10, we’d witnessed a one-month rise of 163% as the stock temporarily cracked through the 200DMA. We’ll look for it to hold support at or above previous resistance in the 1.70 area on any pullbacks.


Fresh Options Idea

For a closing idea on this short week, we’ve taken notice of the chart on iShares Silver Trust SLV. It’s gapping up moderately in the premarket this morning after recently bouncing off of its lowest price in a couple of months.

Accordingly, today we’re going to look to possibly take advantage of the activity in the SLV $15-16 Weekly Calls* for intraday flip opportunities.
___

*Caution: As always, heed our caution with regard to trading options contracts with a weekly expiration on Friday. It’s something only to be attempted by advanced traders!


Extended Watchlist:
GDSI, SNST, SIGA SAND, AUY, USLV

Blue Horseshoe Stocks: Final Report of 2014

Good Morning Traders! Here it is- the final report of 2014! We had an amazing year, with huge gainers popping out of the woodwork left, right, and center! We want to take this opportunity to thank all of our readers for being a part of our community, wish you all a Happy New Year while reminding everyone that the best is yet to come… Each year our resolution remains the same: To make the upcoming year our best one ever! We’ve succeeded time and time again, and have no reason to believe that 2015 will be any different so be sure to stay with us! Cheers!


NeuroDerm Ltd. NDRM
NDRM exceeded all expectations yesterday after we caught it on an early morning news scan; it spent the entire day in full-on breakout mode setting records in both price and volume, trading almost 27X the norm over the six week period since the stock’s IPO.

Positive response to yesterday’s early morning press statement hurtled NDRM from an early low of 8.16 all the way up to 19.07 just prior to the close, making gains of up to 134% possible.

We’ll still be standing at the ready for an eventual course correction and chance for a dip-and-rip maneuver, but any way you slice it, NDRM is getting marked down as a huge winner. It’s a great way to close out what has, on the whole, been an absolutely stellar year.

NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson’s Disease (Tue 7:00AM EST)


Precious Metals on Watch: Gold, Silver

GDX and SLV have each been maintaining higher highs and higher lows since reaching a bottom in November. As we head into the New Year, we’re going to devote a good amount of focus to gold and silver, and tracking these indices and their options chains is going to be a good way to do that.

In particular, we’re going to be monitoring a few specific sets of contracts for each play:

  SLV – March $15-15.50 Calls

GDX – March $17.50-$18 Calls

As you can see from the side-by-side chart we drew up below, GDX and SLV are looking similarly ripe. We’ve got SLV breaking the 50-Line on the RSI, and GDX following closely behind in that regard, we’re seeing testing of the 50DMA’s on both charts, and each of the MACD’s are giving the indication of bullish crosses.


Side Note:
We’re also going to radar HMCP, a sub-penny momentum play that has had an interesting past few sessions.


Extended Watchlist:
NRX, RDHL, MIG, CYTK, NEON, BCLI, CVEO